The latest biotechnology news | Bio News
27-boosters

VRBPAC recommends harmonizing COVID vaccines content

Acting upon the Food and Drug Administration’s (FDA) request, the FDA’s Vaccines and ...
Read More
glenn-carstens-peters-piNf3C4TViA-unsplash

China approves eight biotech crops — a promising development

The Biotechnology Innovation Organization (BIO) has welcomed China’s positive development: The country has ...
Read More
COVID-19 vaccine

Bivalent boosters halve infection, hospitalization risk of XBB variants, studies show

Ahead of the U.S. Food and Drug Administration’s (FDA) meeting to discuss the ...
Read More
human-science

Australian scientists work on helping the immune system kill cancer cells

Australian scientists are a step closer to finding new and more effective treatments ...
Read More
BIO-CEO-conference

Partnering is a big deal at the BIO CEO & Investor Conference in NYC, Feb. 6-7

Over the last 10 years, partnering has been an essential driver of the ...
Read More
Antibiotics-1

European lessons on drug price controls teach the U.S. how ‘not to do it’

In light of the drastic rebate hike prompted by inflation and COVID-driven increases ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

BIO Events

Startup Stadium: Tezcat Biosciences targets common cancer mutation

A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer when mutated. The RAS is the most commonly mutated oncogene in human ...
Federal Policy

Psoriasis awareness: The condition is more than skin deep

Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic condition, ...
Health

BIO 2025: As M&A slows, biotechs need to show good data

M&A in biotech has slowed from its peak in 2023 but there are still deals to be done, especially for companies who can present good ...
BIO Events

BIO 2025: How weight loss drugs are disrupting chronic disease

“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and opportunity ...
BIO Events

BIO 2025: Psychedelics go mainstream – what’s next?

When experts discussed clinical uses of psychedelics two years ago at the 2023 Biotechnology Innovation Organization (BIO) International Convention, there was some interest in separating ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top